HIV-1 tat Proteïne (1-9)

HIV-1 tat Protein (1-9) occurs extracellularly and has a role in the immunosuppression of non-HIV-1-infected T cells in acquired AIDS. HIV-1 tat Protein (1-9) is an inhibitor of DP IV. HIV-1 tat Protein (1-9) can be synthesized by phase peptide synthesis with Fmoc (N- (9-fluorenyl) methoxycarbonyl) technique using the peptide synthesizer 431A. HIV-1 tat Protein (1-9) can be studied in research on HIV-1[1].

200203-20-9

12352209

HIV

Anti-infection

Infection; Inflammation/Immunology

O=C(N[C@@H](CC(O)=O)C(N1[C@@H](CCC1)C(N[C@@H](C(C)C)C(N[C@@H](CC(O)=O)C(N2[C@@H](CCC2)C(N[C@@H](CC(N)=O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCC(O)=O)C(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CCSC)N

C43H68N10O17S

1029.12

[1]Wrenger, S., et al., (1997) . The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth. The Journal of biological chemistry, 272 (48), 30283–30288.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-P11152/

Peptides

No Development Reported